HomeFBLG • NASDAQ
add
Fibrobiologics Inc
Previous close
$11.80
Day range
$11.00 - $11.72
Year range
$6.53 - $55.00
Market cap
371.36M USD
Avg Volume
67.67K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.45M | 58.33% |
Net income | -8.46M | -269.76% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.42M | -56.83% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 8.16M | -28.30% |
Total assets | 11.40M | -17.66% |
Total liabilities | 15.26M | 512.69% |
Total equity | -3.86M | — |
Shares outstanding | 31.13M | — |
Price to book | -98.33 | — |
Return on assets | -74.29% | — |
Return on capital | -1,244.59% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -8.46M | -269.76% |
Cash from operations | -4.28M | -133.54% |
Cash from investing | -8.00K | 80.00% |
Cash from financing | 3.28M | -48.99% |
Net change in cash | -1.00M | -122.06% |
Free cash flow | 1.73M | — |
About
Founded
2021
Headquarters
Website
Employees
10